Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Early diagnosis of tufted hair is crucial for managing folliculitis decalvans, a chronic scalp condition.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Folliculitis decalvans was successfully treated with doxycycline and ozenoxacin.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Dermoscopy helped correctly diagnose a skin condition that was previously misidentified as a different hair loss disease.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

CCCA is a common, scarring hair loss in Black women that needs early detection.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Nanotechnology can improve alopecia treatments but faces stability challenges.